Enobia Pharma
Latest round
- Series C
Last raised
- Aug 2009
Total raised
- $106M
Investors
- 8
About Enobia Pharma
Enobia Pharma Inc.Enobia Pharma was founded in 1997 in Montreal, Canada, specializing in biopharmaceutical innovations. The company was acquired by Alexion Pharmaceuticals in December 2011 for USD 610 mn, with possible future milestone payments of USD 470 mn. This acquisition reflects a strategic pivot towards enhancing its capabilities in rare disease therapeutics.com primarily serves as a premium domain name targeted at businesses in the technology, design, and creative sectors. Its core offering is the domain name itself, marketed as a memorable and brandable asset ideal for entities seeking to establish a strong online presence. The platform emphasizes innovation, suggesting that the domain can help evoke a sense of creativity and modernity among its users. The company targets a global client base, offering the domain to entrepreneurs, startups, and established firms alike, looking to enhance their digital footprint.com primarily occurs through the sale of its domain name, as well as additional services like logo creation offered with the purchase. Clients can engage with the company through a straightforward transaction process that includes immediate payment options or a payment plan that distributes the cost over several months. The payment structure is direct-to-consumer, allowing businesses and individuals to buy the domain outright or finance it with a stipulated monthly payment. This model appeals to startups and small businesses who may prefer low initial outlays.Following the acquisition by Alexion Pharmaceuticals in February 2012, Enobia Pharma is focused on expanding its product line and enhancing its market reach within the rare disease sector. While specific upcoming product launches have not been detailed, the company aims to innovate within its therapeutic areas by leveraging its accumulated resources and expertise in biopharmaceuticals.
Who invested in Enobia Pharma
8 investors across 3 rounds
See all investors in Enobia Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Enobia Pharma
Who invested in Enobia Pharma?
Enobia Pharma has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enobia Pharma raised?
Enobia Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Enobia Pharma last raise money?
Enobia Pharma's most recent round on record is a Series C, in Aug 2009.
What does Enobia Pharma do?
Enobia Pharma is a healthcare company.
Where is Enobia Pharma headquartered?
Enobia Pharma is headquartered in Montreal, Canada.
Which VCs invest in companies like Enobia Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Enobia Pharma's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like Enobia Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.